Search Results for: axicabtagene ciloleucel

Yescarta (KTE-C19)

Yescarta (axicabtagene ciloleucel, formerly KTE-C19) is a therapy developed by Kite Pharma for people with aggressive B-cell non-Hodgkin’s Lymphoma (NHL) who have exhausted other treatment options. It is a type of ... Read more